News & Analysis on Clinical Trial Services & Contract Research And Development
Hovione: $170m investment in global capacity
By Jenni Spinner
- Last updated on
Spray-drying and particle engineering specialist Hovione has announced plans to expand facilities around the world, to the tune of an estimated $170m USD. The move to increase its worldwide capacity and capabilities reportedly will support the company’s future growth objectives.
“Hovione is in it for life and what better way to manifest this than through expansion of our global capacity and capabilities. Our sustainable organic growth strategy will allow us to keep true to those values that have been guiding us for more than 60 years,” said Guy Villax, CEO.